20:12 EST Cathie Wood’s ARK Investment bought 147K shares of Crispr Therapeutics (CRSP) today
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Cathie Wood’s ARK Invest Boosts CRISPR Therapeutics (NASDAQ:CRSP) Stake
- Cathie Wood’s ARK Investment bought 133K shares of Crispr Therapeutics today
- Crispr Therapeutics highlights strategic priorities, anticipated milestones
- Crispr Therapeutics proposes to elect Briggs Morrison to board
- Crispr Therapeutics price target lowered to $85 from $98 at BofA
Questions or Comments about the article? Write to editor@tipranks.com